Screening for Pancreatic Cancer

Aimee L Lucas¹, Fay Kastrinos^{2

3}

Affiliations

¹ Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
² Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
³ Vagelos College of Physicians and Surgeons, Division of Digestive and Liver Diseases, Columbia University Irving Medical Center, New York, New York.

Editorial

Aimee L Lucas et al. JAMA. 2019.

. 2019 Aug 6;322(5):407-408.

doi: 10.1001/jama.2019.9690.

Aimee L Lucas¹, Fay Kastrinos^{2

3}

¹ Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
² Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
³ Vagelos College of Physicians and Surgeons, Division of Digestive and Liver Diseases, Columbia University Irving Medical Center, New York, New York.

No abstract available

Comment on

Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Henrikson NB, Aiello Bowles EJ, Blasi PR, Morrison CC, Nguyen M, Pillarisetty VG, Lin JS. Henrikson NB, et al. JAMA. 2019 Aug 6;322(5):445-454. doi: 10.1001/jama.2019.6190. JAMA. 2019. PMID: 31386140
Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement.
US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Curry SJ, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. US Preventive Services Task Force, et al. JAMA. 2019 Aug 6;322(5):438-444. doi: 10.1001/jama.2019.10232. JAMA. 2019. PMID: 31386141